Clinicopathological Factors Predicting Retroperitoneal Lymph Node Metastasis and Survival in Endometrial Cancer

Japanese Journal of Clinical Oncology

Volumn 28, Issue 11, 1998, Pages 673-678

  Tang, Xiaohai ^a,b   Tanemura, Kenjiro ^a,c   Ye, Weimin ^a   Ohmi, Kazuo ^a   Tsunematsu, Ryuichiro ^a   Yamada, Takuro ^a   Katsumata, Noriyuki ^a   Sonoda, Takahiko ^a  

^a NATIONAL CANCER CENTER   (Japan)

^b SICHUAN CANCER HOSPITAL   (China)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Clinicopathological factors; Endometrial cancer; Lymph node metastasis; Survival

Indexed keywords

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; ENDOMETRIUM TUMOR; FEMALE; HUMAN; HYSTERECTOMY; LYMPH NODE; LYMPH NODE METASTASIS; METASTASIS; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; RETROPERITONEUM; RETROSPECTIVE STUDY; SURVIVAL RATE; UTERINE CERVIX TUMOR;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ADENOSQUAMOUS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RETROPERITONEAL SPACE; RETROSPECTIVE STUDIES; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 0032214198     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/28.11.673     Document Type: Article

References (19)

1. Larson DM, Connor GP, Broste SK, Krawisz BR, Johnson KK. Prognostic significance of gross myometrial invasion with endometrial cancer. Obstet Gynecol 1996;88:394-8.
2. Kaku T, Tsuruchi N, Tsukamoto N, Hirakawa T, Kamura T, Nakano H. Reassessment of myometrial invasion in endometrial cancer. Obstet Gynecol 1994;84:979-82.
3. Cohen CJ. Advanced (FIGO stages III and IV) and recurrent cancer of the endometrium. In: Coppleson M, Monaghan JM, Morrow CP, Tattersall MH, editors. Gynecologic Oncology, 2nd ed. Edinburgh: Churchill Livingstone, 1992;778-98.
4. Kadar N, Homesley HD, Malfetano JH. Prognostic factors in surgical stage III and IV cancer of the endometrium. Obstet Gynecol 1994;84:983-6.
5. Creasman WT, Rutledge FN. The prognostic value of pentoneal cytology in gynecologic malignant disease. Am J Obstet Gynecol 1976;110:773-81.
6. Vecek N, Marinovic T, Ivic J, Jukic S, Nola M, Dzanic-Cemalovic N, et al. Prognostic impact of pentoneal cytology in patients with endometrial cancer. Eur J Gynaecol Oncol 1993;14:380-5.
7. Kato T, Yamada T, Tanemura K, Tsunematsu R, Ohmi K, Sonoda T. Clinical significance of peritoneal cytology in patients with endometrial adenocarcinoma. Sanka To Fujinka 1989;56:1759-63 (in Japanese)
8. Yokoyama Y, Maruyama H, Sato S, Saito Y. Indispensability of pelvic and paraaortic lymphadenectomy in endometrial cancers. Gynecol Oncol 1997;64:411-7.
9. Onda T, Yoshikawa H, Mizutani K, Mishima M, Yokota H, Nagano H, et al. Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy. Br J Cancer 1997;75:1836-41.
10. Kodama S, Kase H, Tanaka K, Matsui K. Multivariate analysis of prognostic factors in patients with endometrial cancer. Int J Gynaecol Obstet 1996;53:23-30.
11. Behbakht K, Yordan EL, Casey C, DeGeest K, Massad LS, Kirschner CV, et al. Prognostic indicators of survival in advanced endometrial cancer. Gynecol Oncol 1994;55:363-7.
12. Lampe B, Kurzl R, Hantschmann P. Prognostic factors that predict pelvic lymph node metastasis from endometrial cancer. Cancer 1994;74.2502-8.
13. Kosary CL. FIGO stage, histology, histologic grade, age and race as prognostic factors on determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva and vagina. Semin Sure Oncol 1994 10:31-46.
14. Inoue Y, Obata L, Abe K, Ohmura G, Doh K, Yoshioka T, et al. The prognostic significance of vascular invasion by endometrial cancer. Cancer 1996;78:1447-51.
15. Tsuruchi N, Kaku T, Kamura T, Tsukamoto N, Tsuneyoshi M, Akazawa K et al The prognostic significance of lymphovascular space invasion in endometrial cancer when conventional hemotoxylin and eosin staining is compared to immunohistochemical staining. Gynecol Oncol 1995;57 307-12.
16. Creasman WT, Morrow CP, Bundy L The surgical pathological spread pattern of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 1987;60:2035-41.
17. Corn BW, Lanciano RM, Agostino RD, Kiggundu E, Dunton CJ, Purser P, et al. The relationship of local and distant failure from endometrial cancer: defining a clinical paradigm. Gynecol Oncol 1997 66:411-6.
18. Tang X, Muramatsu Y, Yajima M, Sonoda T. Endometrium-myometrium ratio: a newly proposed diagnostic parameter on magnetic resonance imaging assessment of myometrial invasion by endometrial cancer. Jpn J Clin Oncol 1993;23:278-83.
19. Sonoda T Clinical diagnosis of endometrial cancer: especially for discussion about primary lesion. Sanka To Fujinka 1987;56:2117-25 (in Japanese).